Suppr超能文献

使用猪尾导管行碘化滑石粉胸膜固定术治疗恶性胸腔积液

Pleurodesis with iodized talc for malignant effusions using pigtail catheters.

作者信息

Thompson R L, Yau J C, Donnelly R F, Gowan D J, Matzinger F R

机构信息

Department of Pharmaceutical Services, Ottawa Civic Hospital, Ontario, Canada.

出版信息

Ann Pharmacother. 1998 Jul-Aug;32(7-8):739-42. doi: 10.1345/aph.17435.

Abstract

OBJECTIVE

To assess the efficacy of using an iodized talc slurry as a sclerosing agent instilled into the pleural space via a 12-French pigtail catheter for controlling malignant pleural effusions.

DESIGN

A prospective study in which patients were followed until their death.

SETTING

A university-affiliated tertiary-care teaching hospital.

PATIENTS

Medical oncology patients admitted with symptomatic malignant pleural effusions were considered for iodized talc pleurodesis.

MAIN OUTCOME MEASURES

The control of pleural effusion. Treatment failure was defined as any reaccumulation of fluid in the pleural space.

RESULTS

Fifteen patients were treated for a total of 17 instillations. The median follow-up on all patients until death was 6 months (range 1-20). The most frequent adverse effect in the study group was pleuritic chest pain (60%). The probability of control of effusion, as determined by the method of Kaplan-Meier, was 81% (SEM 9.7%). The cost of preparing 5 g of iodized talc was $4.32 (US).

CONCLUSIONS

Iodized talc slurry instilled through a small-bore pigtail catheter is a safe, economical, and effective treatment for malignant pleural effusion.

摘要

目的

评估通过12法式猪尾导管向胸腔内注入碘化滑石粉浆作为硬化剂控制恶性胸腔积液的疗效。

设计

一项前瞻性研究,对患者进行随访直至死亡。

地点

一所大学附属的三级护理教学医院。

患者

因症状性恶性胸腔积液入院的医学肿瘤学患者被纳入碘化滑石粉胸膜固定术研究。

主要观察指标

胸腔积液的控制情况。治疗失败定义为胸腔内再次积液。

结果

15例患者共接受了17次注入治疗。所有患者直至死亡的中位随访时间为6个月(范围1 - 20个月)。研究组最常见的不良反应是胸膜炎性胸痛(60%)。根据Kaplan-Meier方法确定的积液控制概率为81%(标准误9.7%)。制备5克碘化滑石粉的成本为4.32美元(美国)。

结论

通过细孔猪尾导管注入碘化滑石粉浆是一种安全、经济且有效的恶性胸腔积液治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验